Research Partnership continues to expand in the US
We are pleased to announce a number of appointments across our US offices.
Mariana Servin has joined the company’s New York office as Quantitative Director. Mariana has over 18 years’ experience in market research and consulting for pharmaceutical, biotech, medical device and life science clients. She has worked in senior roles for a variety of research and advisory organisations including Quintiles Consulting, Decisions Resources Group and Ipsos Healthcare. Mariana has a wealth of experience in both qualitative and quantitative research, including global work covering Europe, Asia-Pacific and Latin American markets. She joins Research Partnership with a remit for supporting the quantitative side of the business, especially in advanced analytics.
Therapy Watch appoints new Associate Director
Research Partnership is delighted to welcome Mark Hollis who has joined the Therapy Watch team in London.
Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA (IMS Health), where he led field work, analytics, forecasting and report writing for the Middle East and North Africa region.
Sabera Hyderally appointed Head of MedTech North America
Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.
Sabera has over 20 years’ experience in market research, specifically on the agency side. Most recently she was at Lieberman where for the last 7 years she held the position of Executive Vice President of Health.
Dan Coffin joins London Headquarters as Director
Research Partnership is delighted to welcome Dan Coffin who has joined the company’s global head office in London
Dan Coffin joins Research Partnership as Director for the EU region. Dan has over 18 years’ experience in the pharmaceutical sector, with particular interest in digital therapy and the growing health-tech arena. Dan brings experience from the agency side, strengthened by client-side roles at Roche and Johnson & Johnson. Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm. He is an active industry contributor and has been a BHBIA Board director since 2013.